López-Contreras Ana Karen, Martínez-Ruiz María Guadalupe, Olvera-Montaño Cecilia, Robles-Rivera Ricardo Raúl, Arévalo-Simental Diana Esperanza, Castellanos-González José Alberto, Hernández-Chávez Abel, Huerta-Olvera Selene Guadalupe, Cardona-Muñoz Ernesto German, Rodríguez-Carrizalez Adolfo Daniel
Department of Physiology, Health Sciences University Center, Institute of Clinical and Experimental Therapeutics, University of Guadalajara, Guadalajara, Jalisco 44340, Mexico.
Department of Ophthalmology, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco 44280, Mexico.
Antioxidants (Basel). 2020 Sep 20;9(9):891. doi: 10.3390/antiox9090891.
Diabetic retinopathy is one of the leading causes of visual impairment and morbidity worldwide, being the number one cause of blindness in people between 27 and 75 years old. It is estimated that ~191 million people will be diagnosed with this microvascular complication by 2030. Its pathogenesis is due to alterations in the retinal microvasculature as a result of a high concentration of glucose in the blood for a long time which generates numerous molecular changes like oxidative stress. Therefore, this narrative review aims to approach various biomarkers associated with the development of diabetic retinopathy. Focusing on the molecules showing promise as detection tools, among them we consider markers of oxidative stress (TAC, LPO, MDA, 4-HNE, SOD, GPx, and catalase), inflammation (IL-6, IL-1ß, IL-8, IL-10, IL-17A, TNF-α, and MMPs), apoptosis (NF-kB, , and caspases), and recently those that have to do with epigenetic modifications, their measurement in different biological matrices obtained from the eye, including importance, obtaining process, handling, and storage of these matrices in order to have the ability to detect the disease in its early stages.
糖尿病视网膜病变是全球视力损害和发病的主要原因之一,是27至75岁人群失明的首要原因。据估计,到2030年将有1.91亿人被诊断患有这种微血管并发症。其发病机制是由于长期血液中高浓度葡萄糖导致视网膜微血管改变,进而产生许多分子变化,如氧化应激。因此,本叙述性综述旨在探讨与糖尿病视网膜病变发展相关的各种生物标志物。重点关注有望作为检测工具的分子,其中我们考虑氧化应激标志物(总抗氧化能力、脂质过氧化、丙二醛、4-羟基壬烯醛、超氧化物歧化酶、谷胱甘肽过氧化物酶和过氧化氢酶)、炎症标志物(白细胞介素-6、白细胞介素-1β、白细胞介素-8、白细胞介素-10、白细胞介素-17A、肿瘤坏死因子-α和基质金属蛋白酶)、凋亡标志物(核因子-κB、[此处原文缺失部分内容]和半胱天冬酶),以及最近与表观遗传修饰有关的标志物,它们在从眼睛获取的不同生物基质中的测量,包括这些基质的重要性、获取过程、处理和储存,以便能够在疾病早期阶段进行检测。